U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863194) titled 'Probiotic Supplementation and Disease Progression in CKD: a Randomized Trial' on March 03.
Brief Summary: The goal of this clinical trial is to learn whether probiotic supplementation can slow disease progression in patients with moderate to severe chronic kidney disease (CKD). The trial will also assess the safety of probiotics in these patients.
The main questions the study aims to answer are:
Does probiotic supplementation improve kidney function by reducing serum creatinine levels and protein in urine? Does it reduce inflammation and metabolic imbalances in CKD patients? Does it affect gut microbiota composition and lower harm...